CannaPharmaRX Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dean Medwid
Chief executive officer
US$237.6k
Total compensation
| CEO salary percentage | 58.3% |
| CEO tenure | 1.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$7m |
| Dec 31 2023 | US$238k | US$139k | US$4m |
Compensation vs Market: Dean's total compensation ($USD237.56K) is below average for companies of similar size in the US market ($USD683.22K).
Compensation vs Earnings: Insufficient data to compare Dean's compensation with company performance.
CEO
Dean Medwid (56 yo)
1.1yrs
Tenure
US$237,560
Compensation
Mr. Dean P. Medwid was Director at New Leaf Ventures Inc since August 2023 until February 13, 2023. He also served as CEO at New Leaf Ventures Inc since August 2023 until February 13, 2024. He is the Chief...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 5.3yrs | no data | 0.095% $ 8.8k | |
| Director | 5.4yrs | US$148.77k | 0.15% $ 14.1k | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data |
3.1yrs
Average Tenure
53.5yo
Average Age
Experienced Board: CPMD's board of directors are considered experienced (3.1 years average tenure).